miR-373-3p targeting LATS2 and OXR1 enhances esophageal squamous cell carcinoma progression, and its expression was vigorously attenuated in the serum of patients with tumor resection [39]. This evidence concerns the gene LATS2 and esophageal squamous cell carcinoma.